Nonalcoholic Fatty Liver Disease in Children

Jake P Mann, Luca Valenti, Eleonora Scorletti, Christopher D Byrne, Valerio Nobili

Research output: Contribution to journalReview article

Abstract

Nonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in children who present with particular risk factors including obesity, sedentary lifestyle, and/or a predisposing genetic background. The worldwide prevalence of NAFLD in children is a worrying phenomenon because this disease is closely associated with the development of both cirrhosis and cardiometabolic syndrome in adulthood. To date, the etiopathogenesis of primary NAFLD in children is unknown. Understanding the pathogenetic mechanisms provides the basis to characterize early predictors of the disease and noninvasive diagnostic tools and to design novel specific treatments and possible management strategies. Despite a few clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD, no treatment exists for children with NAFLD. In this review, the authors provide an overview of current concepts in epidemiology, histological features, etiopathogenesis, diagnosis, and treatment of NAFLD in pediatric population.

Original languageEnglish
Pages (from-to)1-13
Number of pages13
JournalSeminars in Liver Disease
Volume38
Issue number1
DOIs
Publication statusPublished - Feb 2018

Fingerprint

Sedentary Lifestyle
Non-alcoholic Fatty Liver Disease
Life Style
Epidemiology
Fibrosis
Therapeutics
Obesity
Antioxidants
Clinical Trials
Pediatrics
Liver
Population
Genetic Background

Keywords

  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Child
  • Child, Preschool
  • Comorbidity
  • Disease Progression
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Liver/pathology
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease/diagnosis
  • Pediatric Obesity/diagnosis
  • Prevalence
  • Prognosis
  • Risk Factors
  • Sedentary Behavior
  • Young Adult

Cite this

Nonalcoholic Fatty Liver Disease in Children. / Mann, Jake P; Valenti, Luca; Scorletti, Eleonora; Byrne, Christopher D; Nobili, Valerio.

In: Seminars in Liver Disease, Vol. 38, No. 1, 02.2018, p. 1-13.

Research output: Contribution to journalReview article

Mann, Jake P ; Valenti, Luca ; Scorletti, Eleonora ; Byrne, Christopher D ; Nobili, Valerio. / Nonalcoholic Fatty Liver Disease in Children. In: Seminars in Liver Disease. 2018 ; Vol. 38, No. 1. pp. 1-13.
@article{fe4ed58a4cf842109ad1027357cf8280,
title = "Nonalcoholic Fatty Liver Disease in Children",
abstract = "Nonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in children who present with particular risk factors including obesity, sedentary lifestyle, and/or a predisposing genetic background. The worldwide prevalence of NAFLD in children is a worrying phenomenon because this disease is closely associated with the development of both cirrhosis and cardiometabolic syndrome in adulthood. To date, the etiopathogenesis of primary NAFLD in children is unknown. Understanding the pathogenetic mechanisms provides the basis to characterize early predictors of the disease and noninvasive diagnostic tools and to design novel specific treatments and possible management strategies. Despite a few clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD, no treatment exists for children with NAFLD. In this review, the authors provide an overview of current concepts in epidemiology, histological features, etiopathogenesis, diagnosis, and treatment of NAFLD in pediatric population.",
keywords = "Adolescent, Adult, Age of Onset, Aged, Child, Child, Preschool, Comorbidity, Disease Progression, Female, Humans, Infant, Infant, Newborn, Liver/pathology, Male, Middle Aged, Non-alcoholic Fatty Liver Disease/diagnosis, Pediatric Obesity/diagnosis, Prevalence, Prognosis, Risk Factors, Sedentary Behavior, Young Adult",
author = "Mann, {Jake P} and Luca Valenti and Eleonora Scorletti and Byrne, {Christopher D} and Valerio Nobili",
note = "Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.",
year = "2018",
month = "2",
doi = "10.1055/s-0038-1627456",
language = "English",
volume = "38",
pages = "1--13",
journal = "Seminars in Liver Disease",
issn = "0272-8087",
publisher = "Thieme Medical Publishers, Inc.",
number = "1",

}

TY - JOUR

T1 - Nonalcoholic Fatty Liver Disease in Children

AU - Mann, Jake P

AU - Valenti, Luca

AU - Scorletti, Eleonora

AU - Byrne, Christopher D

AU - Nobili, Valerio

N1 - Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

PY - 2018/2

Y1 - 2018/2

N2 - Nonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in children who present with particular risk factors including obesity, sedentary lifestyle, and/or a predisposing genetic background. The worldwide prevalence of NAFLD in children is a worrying phenomenon because this disease is closely associated with the development of both cirrhosis and cardiometabolic syndrome in adulthood. To date, the etiopathogenesis of primary NAFLD in children is unknown. Understanding the pathogenetic mechanisms provides the basis to characterize early predictors of the disease and noninvasive diagnostic tools and to design novel specific treatments and possible management strategies. Despite a few clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD, no treatment exists for children with NAFLD. In this review, the authors provide an overview of current concepts in epidemiology, histological features, etiopathogenesis, diagnosis, and treatment of NAFLD in pediatric population.

AB - Nonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in children who present with particular risk factors including obesity, sedentary lifestyle, and/or a predisposing genetic background. The worldwide prevalence of NAFLD in children is a worrying phenomenon because this disease is closely associated with the development of both cirrhosis and cardiometabolic syndrome in adulthood. To date, the etiopathogenesis of primary NAFLD in children is unknown. Understanding the pathogenetic mechanisms provides the basis to characterize early predictors of the disease and noninvasive diagnostic tools and to design novel specific treatments and possible management strategies. Despite a few clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD, no treatment exists for children with NAFLD. In this review, the authors provide an overview of current concepts in epidemiology, histological features, etiopathogenesis, diagnosis, and treatment of NAFLD in pediatric population.

KW - Adolescent

KW - Adult

KW - Age of Onset

KW - Aged

KW - Child

KW - Child, Preschool

KW - Comorbidity

KW - Disease Progression

KW - Female

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - Liver/pathology

KW - Male

KW - Middle Aged

KW - Non-alcoholic Fatty Liver Disease/diagnosis

KW - Pediatric Obesity/diagnosis

KW - Prevalence

KW - Prognosis

KW - Risk Factors

KW - Sedentary Behavior

KW - Young Adult

U2 - 10.1055/s-0038-1627456

DO - 10.1055/s-0038-1627456

M3 - Review article

C2 - 29471561

VL - 38

SP - 1

EP - 13

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

SN - 0272-8087

IS - 1

ER -